Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Surjeet Singh

BSc, PhD


Clinical Trials Manager

I joined SITU (NDS) in November 2014 as the Clinical Trials Manager/Operational Lead. I am responsible for managing the portfolio of surgical trials and trial managers.

I obtained a PhD degree in Non-Viral Gene Therapy from the School of Chemistry, University of Birmingham.  After which I worked as a formulation scientist at Aphton Corporation and then moved to lead a formulation team at Glide Pharma.  During my time at Glide Pharma (http://glide-technologies.com) I was highly involved in setting up and running two Phase 1 CTIMP clinical trials including the GMP manufacture of the IMP.  I joined Oxford University in 2010, to manage a multi-centre vasculitis study called TABUL which was funded by NIHR HTA programme (CI - Prof Raashid Luqmani, NDORMS, http://www.nets.nihr.ac.uk/projects/hta/086401 ), after successfully completion of recruitment and analysis phase in 2014, I decided to move to NDS. I am also a member of the Oxford C Ethics Committee since January 2013.

False False

Recent Publications

5 View 14 more »